Replies to post #444881 on Anavex Life Sciences Corp (AVXL)

[BAR123]

George happy new year to you and your family. I doubt that they have started the NDA yet as that would be a material event and they haven’t put out a press release. I do think there are a lot of moving parts going on right now, and we don’t know what most of them are. For example, a partnership or partnerships, etc. I also think that we will see the Rett data and the peer review before the JP Morgan conference. That gives them a lot to talk about at the conference. Hoping for a triple to $30 based on the strong Rett results and even more importantly an unbelievable peer review that will conclusively put the shorts out of business and validate blarcamisine.

[BIOChecker4]

A online search shows that rolling NDA submissions are typically announced. Here are a just few examples of the many I found:

https://investors.biogen.com/news-releases/news-release-details/sage-therapeutics-and-biogen-initiate-rolling-submission-new

https://www.parentprojectmd.org/santhera-and-reveragen-start-rolling-nda-submission-to-the-fda-for-vamorolone-for-the-treatment-of-duchenne/

https://ir.exelixis.com/news-releases/news-release-details/exelixis-initiates-rolling-submission-us-new-drug-application

I think we can safely say that if Anavex has started the rolling NDA it would have been announced.

DOG bless,